Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.

MLA

Feng, Wei, et al. “Novel Topoisomerase I-Targeting Antitumor Agents Synthesized from the N,N,N-Trimethylammonium Derivative of ARC-111, 5H-2,3-Dimethoxy-8,9-Methylenedioxy-5-[(2-N,N,N-Trimethylammonium)Ethyl]Dibenzo[c,h][1,6]Naphthyridin-6-One Iodide.” European Journal of Medicinal Chemistry, vol. 44, no. 9, Sept. 2009, pp. 3433–38. EBSCOhost, https://doi.org/10.1016/j.ejmech.2009.02.004.

APA

Feng, W., Satyanarayana, M., Tsai, Y.-C., Liu, A. A., Liu, L. F., & LaVoie, E. J. (2009). Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide. European Journal of Medicinal Chemistry, 44(9), 3433–3438. https://doi.org/10.1016/j.ejmech.2009.02.004

Chicago

Feng, Wei, Mavurapu Satyanarayana, Yuan-Chin Tsai, Angela A Liu, Leroy F Liu, and Edmond J LaVoie. 2009. “Novel Topoisomerase I-Targeting Antitumor Agents Synthesized from the N,N,N-Trimethylammonium Derivative of ARC-111, 5H-2,3-Dimethoxy-8,9-Methylenedioxy-5-[(2-N,N,N-Trimethylammonium)Ethyl]Dibenzo[c,h][1,6]Naphthyridin-6-One Iodide.” European Journal of Medicinal Chemistry 44 (9): 3433–38. doi:10.1016/j.ejmech.2009.02.004.